Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Patrick Soon-Shiong
AddedMar 31, 2024
UpdatedJun 28, 2026
Patrick Soon-Shiong

Patrick Soon-Shiong

Board Member, Nantkwest

Crunchbase

Patrick Soon-Shiong's Career

Nantkwest
Nantkwest

Culver City, CA, US

Board Member· Board
ImmunityBio
ImmunityBio

San Diego, CA, US

Board Member· Board
NantHealth
NantHealth

Culver City, CA, US

Board Member· Board
Tensorcom
Tensorcom

Carlsbad, CA, US

Board Member· Board
NantEnergy
NantEnergy

Scottsdale, AZ, US

Board Member· Board
Nant Capital
Nant Capital

Culver City, CA, US

Board Member· Board
NantMobile
NantMobile

Culver City, CA, US

Board Member· Board
NantOmics
NantOmics

Culver City, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Patrick Soon-Shiong's Career

Nantkwest
Nantkwest
Public$103.5M512014Culver City, CA, US
Board Member· Board

Leadership at Nantkwest

Wesley ClarkWesley ClarkBoard Member
Christobel E SeleckyChristobel E SeleckyBoard Member
Rich AdcockRich AdcockCEO
ImmunityBio
ImmunityBio
Public$1.1B5872014San Diego, CA, US
Board Member· Board

Leadership at ImmunityBio

Christobel SeleckyChristobel SeleckyBoard Member
Cheryl CohenCheryl CohenBoard Member
Hans KlingemannHans KlingemannBoard Member
Linda MaxwellLinda MaxwellBoard Member

Similar to ImmunityBio

NantkwestNantkwestCulver City, CA, USCancer Treatment, Immunotherapyest. 2014NantkwestCulver City, CA, US · est. 2014

ImmunityBio, Inc.: A US-based biotech firm specializing in immunotherapy for cancer and infectious diseases.

Public · $103.5M51
INmune BioINmune BioBoca Raton, FL, USCancer Treatmentsest. 2015INmune BioBoca Raton, FL, US · est. 2015

INmune Bio Inc., a US-based clinical-stage biotech firm, specializes in developing cancer treatments.

Public · $103.2M17
ImmunomeImmunomeExton, PA, USCancer Therapiesest. 2008ImmunomeExton, PA, US · est. 2008

Immunome, a Philadelphia-based biotech company, develops innovative cancer immunotherapies.

Public · $218.9M48
ImmuneeringImmuneeringCambridge, MA, USCancer Drugsest. 2008ImmuneeringCambridge, MA, US · est. 2008

Immuneering: A biopharmaceutical leader innovating unique medicines for complex diseases like cancer.

Public · $87.2M79
NantHealth
NantHealth
Public$980.2M3402010Culver City, CA, US
Board Member· Board

Leadership at NantHealth

Kirk K. CalhounKirk K. CalhounBoard Member
Michael D BlaszykMichael D BlaszykBoard Member

Similar to NantHealth

NavisHealthNavisHealthSanta Clara, CA, USHealthcare, IT Solutionsest. 2011NavisHealthSanta Clara, CA, US · est. 2011

NavisHealth: Silicon Valley-based digital health IT solutions provider, delivering innovative, secure, and interoperable solutions for US healthcare organizations.

Pre-Seed · $1M75
n1 Healthn1 HealthRichmond, VA, USHealthcare Plansest. 2010n1 HealthRichmond, VA, US · est. 2010

n1Health: An online platform offering personalized healthcare plans for patient-focused care.

Seed · $3.4M15
Clarify Health SolutionsClarify Health SolutionsSan Francisco, CA, USHealthcare Softwareest. 2015Clarify Health SolutionsSan Francisco, CA, US · est. 2015

Clarify Health Solutions: Providing data-driven healthcare software for optimized patient care in the US.

Series D · $328M261
Notable HealthNotable HealthSan Mateo, CA, USHealthcare Softwareest. 2017Notable HealthSan Mateo, CA, US · est. 2017

Notable Health: A health tech firm enhancing patient-physician interactions via intelligent automation.

Series B · $119.2M274
Tensorcom
Tensorcom
Series A$24M752010Carlsbad, CA, US
Board Member· Board

Leadership at Tensorcom

Orang DialamehOrang DialamehCo-Founder

Similar to Tensorcom

TensorCommTensorCommWestminster, CO, USNetwork Solutionsest. 2001TensorCommWestminster, CO, US · est. 2001

TensorComm, Inc. develops interference cancellation tech for enhanced 3G/4G network performance globally.

Series C · $9.3M5
Pulse~LinkPulse~LinkCarlsbad, CA, USSemiconductorsest. 2000Pulse~LinkCarlsbad, CA, US · est. 2000

Pulse~LINK: A California-based semiconductor firm specializing in ultra-wideband technology for wired and wireless networks.

Series D · $30M15
TfwirelessTfwirelessMinneapolis, MN, USest. 2021TfwirelessMinneapolis, MN, US · est. 2021

TFWireless: Innovating cost-effective, high-performance wireless communication technology.

Angel · $256k2
NxbeamNxbeamLos Alamitos, CA, USCommunication Products, Wireless Productsest. 2018NxbeamLos Alamitos, CA, US · est. 2018

Nxbeam provides next-gen wireless communication products, powering the future of ICT.

Seed · $150k3
NantEnergy
NantEnergy
Series D$61.6M352008Scottsdale, AZ, US
Board Member· Board

Leadership at NantEnergy

Jameson J. McJunkinJameson J. McJunkinBoard Member
Cody FriesenCody FriesenFounder
Steve LockardSteve LockardBoard Member
Lee ScottLee ScottBoard Member

Similar to NantEnergy

On.EnergyOn.EnergyMiami, FL, USEnergy Storage, Softwareest. 2016On.EnergyMiami, FL, US · est. 2016

On.Energy: AI-powered energy management and smart storage solutions developer.

Series D · $160M75
DayLyte BatteriesDayLyte BatteriesKnoxville, TN, USBatteriesest. 2020DayLyte BatteriesKnoxville, TN, US · est. 2020

DayLyte Batteries: Revolutionizing renewable energy with cost-effective, high-density Metal-air batteries for EVs and drones.

Pre-Seed · $1.1M2
EnergyReEnergyReNew York City, NY, USEnergy Storage, Renewable Energyest. 2020EnergyReNew York City, NY, US · est. 2020

EnergyRe: Pioneering the clean energy future as a leading solutions provider.

Private Equity · $1.2B75
AnthroAnthroSan Jose, CA, USBatteries, Energy Storageest. 2020AnthroSan Jose, CA, US · est. 2020

Anthro: An advanced materials company innovating energy storage solutions for a battery-powered future.

Seed · $7.2M23
Nant Capital
Nant Capital
Investment FirmInvestment Firm$140M72012Culver City, CA, US
Board Member· Board

Leadership at Nant Capital

Richard BinierRichard BinierCEO
Patrick Soon‐ShiongPatrick Soon‐ShiongBoard Member
NantMobile
NantMobile
Series D$110M2002013Culver City, CA, US
Board Member· Board
NantOmics
NantOmics
Series A$250.8M322013Culver City, CA, US
Board Member· Board

Patrick Soon-Shiong's Co-Investors

Dakin SlossDakin SlossCo-invested · Heliogen Series AKittu KolluriKittu KolluriCo-invested · Heliogen Series ARashaun WilliamsRashaun WilliamsCo-invested · Heliogen Corporate RoundGordon CrawfordGordon CrawfordCo-invested · Heliogen Corporate RoundSteve CaseSteve CaseCo-invested · Heliogen SeedBill GatesBill GatesCo-invested · Heliogen SeedSunmeet JollySunmeet JollyCo-invested · Heliogen SeedWill MurphyWill MurphyCo-invested · Heliogen Series C

Patrick Soon-Shiong's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · Dunamu

People Similar to Patrick Soon-Shiong

Guo-Liang YuGuo-Liang YuBoard Member · NvigenJuan EnriquezJuan EnriquezFounder & CEO · BiotechonomyDavid PeraltaDavid PeraltaBoard Member · WpmcChan NamgongChan NamgongFounder & CEO · OncotectOnyema OsuagwuOnyema OsuagwuCEO · BioNanoTech